These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25595234)

  • 21. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program.
    Wang P; Chong SL; Tan RL; Luo N
    Eur J Health Econ; 2023 Apr; 24(3):393-398. PubMed ID: 35661940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods Used to Identify, Test, and Assess Impact on Preferences of Bolt-Ons: A Systematic Review.
    Geraerds AJLM; Bonsel GJ; Janssen MF; Finch AP; Polinder S; Haagsma JA
    Value Health; 2021 Jun; 24(6):901-916. PubMed ID: 34119088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of the development and testing of additional dimensions for the EQ-5D descriptive system.
    Kangwanrattanakul K; Phimarn W
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):431-443. PubMed ID: 31244348
    [No Abstract]   [Full Text] [Related]  

  • 25. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
    Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
    Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extending the EQ-5D: the case for a complementary set of 4 psycho-social dimensions.
    Chen G; Olsen JA
    Qual Life Res; 2023 Feb; 32(2):495-505. PubMed ID: 36125601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing and testing a cognitive bolt-on for the EQ-5D-Y (Youth).
    Ludwig K; Surmann B; Räcker E; Greiner W
    Qual Life Res; 2022 Jan; 31(1):215-229. PubMed ID: 34110552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons.
    Mulhern BJ; Sampson C; Haywood P; Addo R; Page K; Mott D; Shah K; Janssen MF; Herdman M
    Qual Life Res; 2022 Oct; 31(10):3041-3048. PubMed ID: 35486216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adding two culture-specific 'bolt-on' dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes.
    Kangwanrattanakul K; Gross CR; Sunantiwat M; Thavorncharoensap M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):321-329. PubMed ID: 30221564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden.
    Teni FS; Burström K; Devlin N; Parkin D; Rolfson O;
    Health Qual Life Outcomes; 2023 Apr; 21(1):34. PubMed ID: 37038172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
    Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
    Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.
    Kharroubi SA; Beyh YS; Brazier J; Yang Y
    Qual Life Res; 2020 Jun; 29(6):1495-1507. PubMed ID: 32016681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.
    Kularatna S; Whitty JA; Johnson NW; Scuffham PA
    Health Qual Life Outcomes; 2013 Sep; 11():149. PubMed ID: 24070162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manipulating the 5 Dimensions of the EuroQol Instrument: The Effects on Self-Reporting Actual Health and Valuing Hypothetical Health States.
    Tsuchiya A; Bansback N; Hole AR; Mulhern B
    Med Decis Making; 2019 May; 39(4):379-392. PubMed ID: 31161860
    [No Abstract]   [Full Text] [Related]  

  • 36. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
    Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R
    Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis.
    Rencz F; Mukuria C; Bató A; Poór AK; Finch AP
    Qual Life Res; 2022 Oct; 31(10):3049-3060. PubMed ID: 35471487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in injury patients: the added value of extending the EQ-5D-3L with a cognitive dimension.
    Ophuis RH; Janssen MF; Bonsel GJ; Panneman MJ; Polinder S; Haagsma JA
    Qual Life Res; 2019 Jul; 28(7):1941-1949. PubMed ID: 30887386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dutch Tariff for the Five-Level Version of EQ-5D.
    M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
    Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.